More than 86,000 recorded cases of respiratory syncytial virus in 2024 were in children younger than four years old.

COVID-19 was associated with more severe disease outcomes than influenza or respiratory syncytial virus (RSV) during ...

Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study that saw ...

While RSV isn’t any more virulent than the cold, flu or COVID, the same precautions are recommended in order to control its ...

Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...

COVID-19 has been more prevalent and has caused more deaths than flu or respiratory syncytial virus (RSV) in the last three years, according to a study on American veterans published Monday in JAMA ...

As influenza and cold cases, including respiratory syncytial virus (RSV) spike in the nation and Nevada, Intermountain Health ...

Among adults aged 75 and older, RSV was linked to a substantial burden of hospitalizations, ICU admissions, and in-hospital deaths before vaccines were available.

COVID accounted for 3 of 5 (60%) respiratory illnesses among military veterans treated by the U.S. Veterans Health ...

Norovirus is commonly known as the stomach flu. This virus was discovered in 1972 during research into an outbreak of ...

People with diabetes and obesity are at higher risk for severe respiratory illness caused by viruses, including serious ...

The study, published Jan. 20 in The Lancet Infectious Diseases, found the vaccine to be 78% effective against RSV infection, 79% effective against emergency department and urgent care visits and 80% ...